The effect of purinergic P2 receptor blockade on skeletal muscle exercise hyperemia in miniature swine

European Journal of Applied Physiology

Volumn 114, Issue 10, 2014, Pages 2147-2155

  Mortensen, S P ^a   McAllister, R M ^b   Yang, H T ^b   Hellsten, Y ^c   Laughlin, M H ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ATP; Blood flow; P2Y receptors; Skeletal muscle; Vasodilation

Indexed keywords

CIBACRON BLUE F3GA; PURINERGIC P2Y RECEPTOR ANTAGONIST; TRIAZINE DERIVATIVE;

ANIMAL; BLOOD FLOW; DRUG EFFECTS; EXERCISE; FEMALE; HYPEREMIA; METABOLISM; MINIPIG; PHYSIOLOGY; PIG; SKELETAL MUSCLE; VASCULARIZATION;

ANIMALS; FEMALE; HYPEREMIA; MUSCLE, SKELETAL; PHYSICAL EXERTION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; REGIONAL BLOOD FLOW; SWINE; SWINE, MINIATURE; TRIAZINES;

EID: 84932128796     PISSN: 14396319     EISSN: 14396327     Source Type: Journal    
DOI: 10.1007/s00421-014-2932-8     Document Type: Article

References (48)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341
2. Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40–47
3. Brunschweiger A, Müller CE (2006) P2 receptors activated by uracil nucleotides—an update. Curr Med Chem 13:289–312
4. Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335–342
5. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471–1483
6. Burnstock G (2010) Control of vascular tone by purines and pyrimidines. Br J Pharmacol 161:527–529
7. Burnstock G, Ralevic V (2014) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66:102–192
8. Burnstock G, Warland JJ (1987) P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor. Br J Pharmacol 90:383–391
9. Chen BC, Lee CM, Lin WW (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br J Pharmacol 119:1628–1634
10. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG Jr (2000) Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol 278:H1294–H1298
11. Duncker DJ, Stubenitsky R, Tonino PAL, Verdouw PD (2000) Nitric oxide contributes to the regulation of vasomotor tone but does not modulate O2-consumption in exercising swine. Cardiovasc Res 47:738–748
12. Ellsworth ML, Sprague RS (2012) Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J Physiol 590:4985–4991
13. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH (1995) The erythrocyte as a regulator of vascular tone. Am J Physiol 269:H2155–H2161
14. Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1–20
15. González-Alonso J, Olsen DB, Saltin B (2002) Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 91:1046–1055
16. Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309–319
17. Hammer LW, Overstreet CR, Choi J, Hester RL (2003) ATP stimulates the release of prostacyclin from perfused veins isolated from the hamster hindlimb. Am J Physiol 285:R193–R199
18. Hellsten Y, Nyberg M, Jensen LG, Mortensen SP (2012a) Vasodilator interactions in skeletal muscle blood flow regulation. J Physiol 590:6297–6305
19. Hellsten Y, Nyberg M, Mortensen SP (2012b) Contribution of intravascular versus interstitial purines and nitric oxide in the regulation of exercise hyperaemia in humans. J Physiol 590:5015–5023
20. Hillig T, Krustrup P, Fleming I, Osada T, Saltin B, Hellsten Y (2003) Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans. J Physiol 546:307–314
21. Inscho EW (2009) ATP, P2 receptors and the renal microcirculation. Purinergic Signal 5:447–460
22. Kirby BS, Voyles WF, Carlson RE, Dinenno FA (2008) Graded sympatholytic effect of exogenous ATP on postjunctional alpha-adrenergic vasoconstriction in the human forearm: implications for vascular control in contracting muscle. J Physiol 586:4305–4316
23. Laughlin MH, Klabunde RE, Delp MD, Armstrong RB (1989) Effects of dipyridamole on muscle blood flow in exercising miniature swine. Am J Physiol Heart Circ Physiol 257:H1507–H1515
24. Laughlin MH, Davis MJ, Secher NH, van Lieshout JJ, Arce-Esquivel AA, Simmons GH, Bender SB, Padilla J, Bache RJ, Merkus D, and Duncker DJ (2012) Peripheral circulation. Compr Physiol 2:321–447
25. Majid DSA, Iinscho EW, Navar LG (1999) P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J Am Soc Nephrol 10:492–498
26. McAllister RM, Newcomer SC, Pope ER, Turk JR, Laughlin MH (2008) Effects of chronic nitric oxide synthase inhibition on responses to acute exercise in swine. J Appl Physiol 104:186–197
27. McCullough WT, Collins DM, Ellsworth ML (1997) Arteriolar responses to extracellular ATP in striated muscle. Am J Physiol 272:H1886–H1891
28. Mitchell C, Syed N, Tengah A, Gurney AM, Kennedy C (2012) Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands. J Pharmacol Exp Ther 343:755–762
29. Mortensen SP, González-Alonso J, Damsgaard R, Saltin B, Hellsten Y (2007) Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. J Physiol 581:853–861
30. Mortensen SP, Gonzalez-Alonso J, Bune LT, Saltin B, Pilegaard H, Hellsten Y (2009a) ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine. Am J Physiol Regul Integr Comp Physiol 296:R1140–R1148
31. Mortensen SP, Gonzalez-Alonso J, Nielsen JJ, Saltin B, Hellsten Y (2009b) Muscle interstitial ATP and norepinephrine concentrations in the human leg during exercise and ATP infusion. J Appl Physiol 107:1757–1762
32. Mortensen SP, Nyberg M, Thaning P, Saltin B, Hellsten Y (2009c) Adenosine contributes to blood flow regulation in the exercising human leg by increasing prostaglandin and nitric oxide formation. Hypertension 53:993–999
33. Mortensen SP, Thaning P, Nyberg M, Saltin B, Hellsten Y (2011) Local release of ATP into the arterial inflow and venous drainage of human skeletal muscle: insight from ATP determination with the intravascular microdialysis technique. J Physiol 589:1847–1857
34. Rådegran G, Calbet JA (2001) Role of adenosine in exercise-induced human skeletal muscle vasodilatation. Acta Physiol Scand 171:177–185
35. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492
36. Remensnyder J, Mitchell JH, Sarnoff SJ (1962) Functional sympatholysis during muscular activity. Observations on influence of carotid sinus on oxygen uptake. Circ Res 11:370–380
37. Rosenmeier JB, Hansen J, González-Alonso J (2004) Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558:351–365
38. Rosenmeier JB, Yegutkin GG, Gonzalez-Alonso J (2008) Activation of ATP/UTP selective receptors increase blood flow and blunt sympathetic vasoconstriction in human skeletal muscle. J Physiol 586:4993–5002
39. Rubino A, Burnstock G (1996) Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br J Pharmacol 118:1415–1420
40. Saiag B, Bodin P, Shacoori V, Catheline M, Rault B, Burnstock G (1995) Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells. Endothelium 2:279–285
41. Saunders NR, Dinenno FA, Pyke KE, Rogers AM, Tschakovsky ME (2005) Impact of combined NO and PG blockade on rapid vasodilation in a forearm mild-to-moderate exercise transition in humans. Am J Physiol 288:H214–H220
42. Schrage WG, Dietz NM, Joyner MJ (2006) Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise. J Appl Physiol 100:1506–1512
43. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA (1995) Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92:2135–2141
44. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ (1996) ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 271:H2717–H2722
45. Thaning P, Bune LT, Hellsten Y, Pilegaard H, Saltin B, Rosenmeier JB (2010) Attenuated purinergic receptor function in patients with type 2 diabetes. [Article]. Diabetes 59:182–189
46. van Ginneken EE, Meijer P, Verkaik N, Smits P, Rongen GA (2004) ATP-induced vasodilation in human skeletal muscle. Br J Pharmacol 141:842–850
47. Wihlborg AK, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, Lazarowski E, Jacobson KA, Arner A, Erlinge D (2006) Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98:970–976
48. Yegutkin GG, Samburski SS, Mortensen SP, Jalkanen S, Gonzalez-Alonso J (2007) Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. J Physiol 579:553–564